This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Children's National Medical Center. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations in Neurological Treatment by Mohammad Shahid
Introduction
Mohammad Shahid is an accomplished inventor based in Hyattsville, MD (US). He has made significant contributions to the field of neurology, particularly in the treatment of learning disabilities and other neurological disorders. His innovative approach focuses on utilizing SK channel inhibitors to address these complex conditions.
Latest Patents
Shahid holds a patent for the "Treatment of learning disabilities and other neurological disorders with SK channel inhibitor(s)." This patent outlines methods for treating learning disabilities associated with fetal alcohol syndrome and other neurological disorders by administering SK channel blockers, antagonists, inhibitors, or modifiers such as tamapin. His work in this area has the potential to improve the lives of many individuals affected by these disorders.
Career Highlights
Mohammad Shahid is affiliated with the Children's National Medical Center, where he applies his expertise in neurology to advance research and treatment options. His dedication to improving patient outcomes is evident in his innovative work and commitment to the field.
Collaborations
Shahid collaborates with esteemed colleagues, including Masaaki Torii and Kazue Hashimoto-Torii. Their combined efforts contribute to the ongoing research and development of effective treatments for neurological disorders.
Conclusion
In summary, Mohammad Shahid's contributions to the field of neurology through his innovative patent and work at the Children's National Medical Center highlight his commitment to improving treatment options for learning disabilities and neurological disorders. His research continues to pave the way for advancements in this critical area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
